companydata.dkcompanydata.dk

PHARMADANICA A/S: Financial statements 2020

CVR: 19056007

Source: annual report 2020, Danish Business Authority

01/04/2019 – 31/03/2020

PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -777,008 compared with DKK 3,325,178 the year before. Equity in the 2020 report amounted to DKK 18,872,361. The solvency ratio was 92.5%.

Profit/Loss
DKK -777,008
Equity
DKK 18,872,361
Total Assets
DKK 20,400,631

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020---777 t.18.9 mio.-
2019--3.3 mio.19.6 mio.-
2017--12.9 mio.16.3 mio.-
2016---18 t.3.5 mio.-
2015--2.5 mio.3.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMADANICA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Patricia Hec joins the board of PHARMADANICA A/SDec 3, 2020

As of December 3, 2020, Patricia Hec has joined the board of directors of PHARMADANICA A/S.

Annie Renée Simonne Dateu leaves the board of PHARMADANICA A/SDec 3, 2020

As of December 3, 2020, Annie Renée Simonne Dateu has left the board of directors of PHARMADANICA A/S.

About PHARMADANICA A/S

PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.

Source: annual report 2026, Danish Business Authority